Indole-fused saturated ring compound or derivative thereof and use thereof
WO2025223330A1PCT designated stage Publication Date: 2025-10-30DEEPLAKE PHARMACEUTICALS (SHANDONG) CO LTD
Patent Information
- Application Number
- PCT/CN2025/089942
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-04-23
- Filing Date
- 2025-04-18
- Publication Date
- 2025-10-30
Smart Images

Figure CN2025089942_30102025_PF_FP_ABST
Abstract
The present invention provides an indole-fused saturated ring compound or a derivative thereof having the structure shown in Formula I or Formula II, or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, or a solvate thereof, or a prodrug molecule thereof, or a deuterated compound thereof, or a tritiated compound thereof, and a use thereof. The indole-fused saturated ring compound or derivative thereof provided by the present invention are a class of structurally novel compounds. Said class of compounds has good inhibitory activity against both uricase and urate transporters, is a dual XOR / URAT1 inhibitor, and has a strong uric acid-lowering effect, good safety, favorable pharmacokinetic properties, and high druggability. Said compounds can be used for the preparation of uric acid-lowering drugs and for preventing and / or treating gout or hyperuricemia.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
(Aza)indole derivative and use thereof for medical purposes
CN101679251A
Cyan indoles derivative and preparation method and use thereof
CN106008488A
Thioacetic acid compound, composition and application of composition
CN108069940A
Indole derivative, pharmaceutical composition and application of indole derivative in field of central nervous system
CN117586171A
Nitrogen-containing heterocyclic compound and pharmaceutical composition containing the same
WO2008126901A1